GlassScriptPhysician profile
Bonny Lee
NPI 1659735082
$1,575.43
in general payments reported to CMS, 2019-2025
15 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.47 · 2022: $238 · 2023: $563 · 2024: $345 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $591.82 | 2022-2025 | |
| Alcon Vision LLC | $216.40 | 2022-2025 | Clareon, Argos, Rocklatan |
| Sun Pharmaceutical Industries INC. | $159.04 | 2023-2024 | Cequa |
| Glaukos Corporation | $119.86 | 2024-2025 | Idosetr, Idose |
| New World Medical,INC. | $118.44 | 2023-2025 | Streamline, Clearpath, Kahook Dual Blade |
| Merz North America, INC. | $95.47 | 2020 | |
| Apellis Pharmaceuticals, INC. | $65.70 | 2023-2024 | Syfovre |
| Genentech USA, INC. | $54.67 | 2025 | Vabysmo |
| Sight Sciences, INC. | $29.20 | 2022-2024 | Omni Surgical System |
| Rayner Intraocular Lenses Limited | $24.52 | 2024 | Rayone Spheric, Omidria, Rayone Aspheric |
| Harrow Eye, LLC | $23.75 | 2024 | Iheezo |
| Dompe US, INC. | $21.82 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $20.74 | 2024 | Tyrvaya |
| Biotissue Holdings INC. | $17.79 | 2025 | |
| Bausch & Lomb Americas INC. | $16.21 | 2024 | Miebo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bonny Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.